Stockscreener 앱 받기
266.57
3.90%
10.01
시간 외 거래:
266.57
전일 마감가:
$256.56
열려 있는:
$256.56
하루 거래량:
1.18M
Relative Volume:
2.15
시가총액:
$18.70B
수익:
$1.98B
순이익/손실:
$420.90M
주가수익비율:
155.89
EPS:
1.71
순현금흐름:
$218.20M
1주 성능:
-1.03%
1개월 성능:
-0.00%
6개월 성능:
+33.75%
1년 성능:
+28.18%
1일 변동 폭
$256.56
$270.70
1주일 범위
$254.79
$271.18
52주 변동 폭
$160.19
$279.77
인슐렛 코퍼레이션 Stock (PODD) Company Profile
명칭
Insulet Corporation
전화
978-600-7000
주소
100 NAGOG PARK, ACTON, MA
PODD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PODD
Insulet Corporation
|
266.57 | 18.70B | 1.98B | 420.90M | 218.20M | 5.84 |
|
ABT
Abbott Laboratories
|
114.23 | 198.13B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
364.60 | 138.99B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
88.95 | 131.10B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
81.03 | 103.90B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
74.81 | 44.12B | 6.60B | 4.16B | 490.10M | 6.93 |
인슐렛 코퍼레이션 Stock (PODD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-06 | 개시 | Bernstein | Outperform |
| 2024-05-30 | 개시 | Redburn Atlantic | Buy |
| 2024-05-07 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-12-21 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2023-12-04 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-02 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-08-21 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-08-21 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-01-26 | 개시 | Wolfe Research | Peer Perform |
| 2022-11-04 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-10-18 | 개시 | Barclays | Equal Weight |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-07-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-03 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-02-02 | 업그레이드 | UBS | Neutral → Buy |
| 2022-01-31 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-07-21 | 재개 | Cowen | Outperform |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-01 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2021-03-19 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2021-01-29 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-07-28 | 개시 | Wells Fargo | Overweight |
| 2020-04-24 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-03 | 개시 | BofA/Merrill | Neutral |
| 2020-03-31 | 다운그레이드 | Berenberg | Buy → Hold |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2019-12-10 | 개시 | CFRA | Sell |
| 2019-10-23 | 개시 | Stifel | Hold |
| 2019-10-18 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2019-10-14 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2019-10-04 | 다운그레이드 | UBS | Buy → Neutral |
| 2019-10-03 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2019-08-06 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2019-06-10 | 다운그레이드 | Northland Capital | Outperform → Market Perform |
| 2019-05-06 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2018-04-20 | 개시 | Berenberg | Buy |
| 2018-02-22 | 재확인 | Barclays | Overweight |
| 2018-01-08 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2017-11-03 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2017-09-15 | 개시 | Barclays | Overweight |
모두보기
인슐렛 코퍼레이션 주식(PODD)의 최신 뉴스
The Most Significant Trade Secrets Cases Of 2024 - Law360
Executive VP Of Insulet Sold 26% Of Their Shares - Simply Wall St
Insulet Corp. stock outperforms competitors on strong trading day - MarketWatch
Insulet Co. (NASDAQ:PODD) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Here's Why Insulet (NASDAQ:PODD) Can Manage Its Debt Responsibly - Simply Wall St
Insulet corp EVP Benjamin Eric sells $1.17 million in shares By Investing.com - Investing.com Australia
Insulet corp EVP Benjamin Eric sells $1.17 million in shares - Investing.com India
Here's How Much $1000 Invested In Insulet 15 Years Ago Would Be Worth Today - Benzinga
Stocks Fall As Breadth Remains Weak; Fortinet, Insulet, Embraer In FocusVideoIBD - Investor's Business Daily
Virtu Financial LLC Makes New $616,000 Investment in Insulet Co. (NASDAQ:PODD) - MarketBeat
Toronto Dominion Bank Buys 3,117 Shares of Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet Co. (NASDAQ:PODD) Stake Raised by Geode Capital Management LLC - MarketBeat
Insulet's SWOT analysis: tubeless pump maker's stock faces competition - Investing.com
Why Insulet (PODD) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Insulet Co. (NASDAQ:PODD) Shares Sold by Y Intercept Hong Kong Ltd - MarketBeat
Orion Portfolio Solutions LLC Purchases 3,623 Shares of Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet stock soars to 52-week high, reaching $279.42 - Investing.com India
RMD or PODD: Which Is the Better Value Stock Right Now? - Yahoo Finance
Insulet stock soars to 52-week high, reaching $279.42 By Investing.com - Investing.com UK
National Bank of Canada FI Decreases Holdings in Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet corp executive sells $252,192 in common stock By Investing.com - Investing.com Nigeria
Insulet corp executive sells $252,192 in common stock - Investing.com India
Should You Continue to Retain Insulet Stock in Your Portfolio Now? - MSN
Tandem Diabetes (TNDM) and Insulet (PODD) Volatility Attributed to Channel-Check Firm - StreetInsider.com
Google Takes Quantum Leap But Growth Weak Again; AppLovin, Insulet In Focus TooVideoIBD - Investor's Business Daily
Quantinno Capital Management LP Acquires 7,270 Shares of Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet Co. (NASDAQ:PODD) Shares Bought by Nomura Asset Management Co. Ltd. - MarketBeat
3,459 Shares in Insulet Co. (NASDAQ:PODD) Purchased by SGL Investment Advisors Inc. - MarketBeat
Insulet Co. (NASDAQ:PODD) Position Trimmed by Groupama Asset Managment - MarketBeat
XTX Topco Ltd Acquires Shares of 6,351 Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet successfully defends its Intellectual property against EOFlow - Medical Buyer
Insulet wins $452M in lawsuit against rivals over medical device trade secrets - Cardiovascular Business
Jury awards Insulet $452M against Eoflow in trade secrets case - BioWorld Online
Insulet wins $452M in trade secret case By Investing.com - Investing.com Australia
Insulet Wins $452M Trade Secrets Verdict Against EOFlow - USA Herald
Readystate Asset Management LP Trims Holdings in Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet wins $452 mln US verdict against EOFlow in insulin pump secrets case - Reuters
Insulet Wins $452M Jury Verdict in Trade Secrets Battle with EOFlow - USA Herald
Insulet awarded $452M in EOFlow patent fight - MedTech Dive
Insulet Wins $452 Million in Insulin Pump Trade Secrets Trial - Bloomberg Law
Insulet's Legal Win Against EOFlow Over Trade Secret Theft - Finimize
BREAKING: Insulet Corp. Wins $452M In Trade Secret Theft Trial - Law360
Insulet Wins $452 Million Trade Secret Victory Against EOFlow - MPO-mag
Insulet Corporation (PODD) Secures Major Legal Victory with $452 Million Jury Award - GuruFocus.com
Insulet wins $452M in trade secret case - Investing.com India
Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court - Business Wire
Insulet Co. (NASDAQ:PODD) Shares Sold by Parkman Healthcare Partners LLC - MarketBeat
Insulet Co. (NASDAQ:PODD) Shares Sold by The Manufacturers Life Insurance Company - MarketBeat
Beacon Investment Advisory Services Inc. Has $37.84 Million Stock Position in Insulet Co. (NASDAQ:PODD) - MarketBeat
70,213 Shares in Insulet Co. (NASDAQ:PODD) Acquired by Caisse DE Depot ET Placement DU Quebec - MarketBeat
Zurcher Kantonalbank Zurich Cantonalbank Buys 5,031 Shares of Insulet Co. (NASDAQ:PODD) - MarketBeat
인슐렛 코퍼레이션 (PODD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.54%
자본화:
|
볼륨(24시간):